Presentation to Highlight Company’s Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Feb. 6, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer…